<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02892591</url>
  </required_header>
  <id_info>
    <org_study_id>14-1909</org_study_id>
    <nct_id>NCT02892591</nct_id>
  </id_info>
  <brief_title>Cannabis Versus Oxycodone for Pain Relief</brief_title>
  <official_title>A Double-Blind, Placebo-Controlled Crossover Study Comparing the Analgesic Efficacy of Cannabis Versus Oxycodone</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Colorado, Denver</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study investigates the ability of cannabis to reduce chronic back and neck pain and to&#xD;
      reduce sensitivity to an acute painful stimulus. Cannabis will be compared to both oxycodone&#xD;
      and a placebo.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study investigates the ability of cannabis to reduce chronic back and neck pain and to&#xD;
      reduce sensitivity to an acute painful stimulus. Cannabis will be compared to both oxycodone&#xD;
      and a placebo.&#xD;
&#xD;
      Some inclusion/exclusion criteria are purposely omitted at this time to preserve scientific&#xD;
      integrity. They will be included after the trial is complete.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2017</start_date>
  <completion_date type="Anticipated">June 2023</completion_date>
  <primary_completion_date type="Anticipated">June 2023</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain Numeric Rating Scale (NRS) score (Spine Patients)</measure>
    <time_frame>3 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain Threshold (kPa) (Healthy Controls)</measure>
    <time_frame>3 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient Global Impression of Change score</measure>
    <time_frame>3 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Drug effect rating</measure>
    <time_frame>3 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychoactive effect rating</measure>
    <time_frame>3 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mood rating</measure>
    <time_frame>3 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Symbol Digit Modalities Test (SDMT)</measure>
    <time_frame>3 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hopkins Verbal Learning Test Revised (HVLT)</measure>
    <time_frame>3 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Standardized Field Sobriety Test</measure>
    <time_frame>3 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Back Pain</condition>
  <condition>Neck Pain</condition>
  <arm_group>
    <arm_group_label>Cannabis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Medium dose THC, single administration, vaporized</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Oxycodone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>5-10 mg oxycodone hydrochloride, single administration, oral</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>No active study drug</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cannabis</intervention_name>
    <description>vaporized plant material</description>
    <arm_group_label>Cannabis</arm_group_label>
    <other_name>marijuana</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxycodone</intervention_name>
    <description>oral capsule</description>
    <arm_group_label>Oxycodone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo for Cannabis</intervention_name>
    <description>vaporized placebo plant material</description>
    <arm_group_label>Oxycodone</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo for Oxycodone</intervention_name>
    <description>oral placebo capsule</description>
    <arm_group_label>Cannabis</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Overall Inclusion Criteria:&#xD;
&#xD;
          -  Previous smoked or vaporized cannabis exposure&#xD;
&#xD;
          -  Age â‰¥21 years&#xD;
&#xD;
        Overall Exclusion Criteria:&#xD;
&#xD;
          -  Current substance use disorder&#xD;
&#xD;
          -  Current alcohol use disorder&#xD;
&#xD;
          -  Past cannabis abuse/dependence&#xD;
&#xD;
          -  Current use of amphetamine/methamphetamine, barbiturates, benzodiazepines, cocaine,&#xD;
             phencyclidine (PCP), MDMA (ecstasy)&#xD;
&#xD;
          -  Prior adverse reaction to cannabis exposure (paranoia, anxiety, etc.)&#xD;
&#xD;
          -  Allergy to or prior adverse reaction to oxycodone&#xD;
&#xD;
          -  Any condition contraindicative to opioid use (e.g. paralytic ileus)&#xD;
&#xD;
          -  History or diagnosis of schizophrenia or bipolar disorder&#xD;
&#xD;
          -  Current severe depression&#xD;
&#xD;
          -  Uncontrolled hypertension (&gt;139/89)&#xD;
&#xD;
          -  Known cardiovascular disease&#xD;
&#xD;
          -  Known immune system disorder&#xD;
&#xD;
          -  Chronic pulmonary disease (e.g., bronchitis, asthma, COPD, or emphysema)&#xD;
&#xD;
          -  History of seizure disorder&#xD;
&#xD;
          -  Diagnosed inflammatory disease (e.g. Rheumatoid Arthritis (RA))&#xD;
&#xD;
          -  Clinically significant abnormal values on CBC/CMP/EKG tests&#xD;
&#xD;
          -  Cognitive disability that interferes with ability to provide consent or understand&#xD;
             study procedures&#xD;
&#xD;
          -  Inability to refrain from using tobacco for at least 4 hours&#xD;
&#xD;
          -  Pregnant females&#xD;
&#xD;
          -  Lactating females&#xD;
&#xD;
        Additional Exclusion Criteria for SPINE PATIENTS&#xD;
&#xD;
          -  Current regular use of a long acting opioid (e.g. OxyContin, MS Contin, other extended&#xD;
             release formulas)&#xD;
&#xD;
          -  Current high-dose use of immediate release opioid&#xD;
&#xD;
          -  Current high-dose use of nerve-targeted medication&#xD;
&#xD;
          -  Other diagnosed chronic pain syndromes of greater severity than spine condition (e.g.&#xD;
             knee pain )&#xD;
&#xD;
          -  Diagnosed Fibromyalgia&#xD;
&#xD;
          -  Neuropathy not associated with spine condition (e.g. diabetic neuropathy)&#xD;
&#xD;
        Additional Exclusion Criteria for HEALTHY CONTROLS&#xD;
&#xD;
          -  Current acute pain&#xD;
&#xD;
          -  Current chronic pain condition (e.g. fibromyalgia, neuropathy)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emily Lindley, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Colorado, Denver</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Emily Lindley, PhD</last_name>
    <phone>303-724-0923</phone>
    <email>MJPainStudy@ucdenver.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Colorado Anschutz Medical Campus</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emily Lindley, PhD</last_name>
      <phone>303-724-0923</phone>
      <email>MJPainStudy@ucdenver.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 2, 2016</study_first_submitted>
  <study_first_submitted_qc>September 2, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 8, 2016</study_first_posted>
  <last_update_submitted>September 17, 2021</last_update_submitted>
  <last_update_submitted_qc>September 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neck Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Oxycodone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

